Details for New Drug Application (NDA): 211237
✉ Email this page to a colleague
The generic ingredient in ISOPROTERENOL HYDROCHLORIDE is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
Summary for 211237
Tradename: | ISOPROTERENOL HYDROCHLORIDE |
Applicant: | Amring Pharms |
Ingredient: | isoproterenol hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 211237
Mechanism of Action | Adrenergic beta-Agonists |
Suppliers and Packaging for NDA: 211237
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ISOPROTERENOL HYDROCHLORIDE | isoproterenol hydrochloride | INJECTABLE;INJECTION | 211237 | ANDA | Nordic Pharma, Inc. | 69918-731 | 69918-731-11 | 10 VIAL, SINGLE-DOSE in 1 CARTON (69918-731-11) / 1 mL in 1 VIAL, SINGLE-DOSE |
ISOPROTERENOL HYDROCHLORIDE | isoproterenol hydrochloride | INJECTABLE;INJECTION | 211237 | ANDA | Nordic Pharma, Inc. | 69918-731 | 69918-731-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (69918-731-10) / 1 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.2MG/ML | ||||
Approval Date: | May 19, 2021 | TE: | AP | RLD: | No |
Complete Access Available with Subscription